COVID-19 Clinical Trial
Official title:
Efficacy of Teletechnology-assisted Home-based Exercise Program for Severe COVID-19
The aim of this study is to investigate the efficacy of a home-based pulmonary rehabilitation program with the support of teletechnology in COVID-19 survivors. The main questions it aims to answer are: - The change of six-minute walk distance - The change of time of one-minute sit-to-stand test - The change of maximal strength of upper-limb, lower-limb and respiratory muscle - The change of quality of life Participants in the home-based pulmonary rehabilitation group will receive teletechnology-assisted consultations (either by videotelephony or telephone calls) for every 1-2 weeks during the intervention period, and participants in the usual care group will not receive teletechnology-assisted consultations during the intervention period.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | December 2023 |
Est. primary completion date | December 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - Patients are 20 years or more with severe (severe pneumonia) to critical (acute respiratory distress syndrome, sepsis, or septic shock) COVID-19 during hospitalization after deisolation. - Patients are 65 years or more, or ever receiving oral antiviral treatment after deisolation. - Patient have the ability to ambulate on level surface without direct contact of another person, have telecommunication device(s), and provide consent to receive teletechnology-assisted rehabilitation. Exclusion Criteria: - Patients are pregnant or planning for pregnancy. - Patients have cognitive dysfunction, learning disability, uncontrolled arrhythmia or hypertension, or any medical diagnosis other than COVID-19 that would prominently influence their ability to follow instructions and perform exercise. |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Taiwan University Hospital | Taipei City |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Taiwan,
Betschart M, Rezek S, Unger I, Beyer S, Gisi D, Shannon H, Sieber C. Feasibility of an Outpatient Training Program after COVID-19. Int J Environ Res Public Health. 2021 Apr 9;18(8):3978. doi: 10.3390/ijerph18083978. — View Citation
Felten-Barentsz KM, van Oorsouw R, Klooster E, Koenders N, Driehuis F, Hulzebos EHJ, van der Schaaf M, Hoogeboom TJ, van der Wees PJ. Recommendations for Hospital-Based Physical Therapists Managing Patients With COVID-19. Phys Ther. 2020 Aug 31;100(9):1444-1457. doi: 10.1093/ptj/pzaa114. — View Citation
Gloeckl R, Leitl D, Jarosch I, Schneeberger T, Nell C, Stenzel N, Vogelmeier CF, Kenn K, Koczulla AR. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021 May 31;7(2):00108-2021. doi: 10.1183/23120541.00108-2021. eCollection 2021 Apr. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Six-minute walk distance | The distance of six-minute walk test | Week 0 | |
Primary | Six-minute walk distance | The distance of six-minute walk test | Week 4 | |
Primary | Six-minute walk distance | The distance of six-minute walk test | Week 8 | |
Primary | Six-minute walk distance | The distance of six-minute walk test | Week 12 | |
Primary | Six-minute walk distance | The distance of six-minute walk test | Week 24 | |
Secondary | Maximal upper limb strength | Hand grip strength | Week 0 | |
Secondary | Maximal upper limb strength | Hand grip strength | Week 4 | |
Secondary | Maximal upper limb strength | Hand grip strength | Week 8 | |
Secondary | Maximal upper limb strength | Hand grip strength | Week 12 | |
Secondary | Maximal upper limb strength | Hand grip strength | Week 24 | |
Secondary | Maximal lower limb strength | Leg press strength | Week 0 | |
Secondary | Maximal lower limb strength | Leg press strength | Week 4 | |
Secondary | Maximal lower limb strength | Leg press strength | Week 8 | |
Secondary | Maximal lower limb strength | Leg press strength | Week 12 | |
Secondary | Maximal lower limb strength | Leg press strength | Week 24 | |
Secondary | Maximal respiratory muscle strength | Inspiratory and expiratory pressure of respiratory muscle | Week 0 | |
Secondary | Maximal respiratory muscle strength | Inspiratory and expiratory pressure of respiratory muscle | Week 4 | |
Secondary | Maximal respiratory muscle strength | Inspiratory and expiratory pressure of respiratory muscle | Week 8 | |
Secondary | Maximal respiratory muscle strength | Inspiratory and expiratory pressure of respiratory muscle | Week 12 | |
Secondary | Maximal respiratory muscle strength | Inspiratory and expiratory pressure of respiratory muscle | Week 24 | |
Secondary | Quality of life score | Quality of life assessed by Short-form 12 questionnaire | Week 0 | |
Secondary | Quality of life score | Quality of life assessed by Short-form 12 questionnaire | Week 4 | |
Secondary | Quality of life score | Quality of life assessed by Short-form 12 questionnaire | Week 8 | |
Secondary | Quality of life score | Quality of life assessed by Short-form 12 questionnaire | Week 12 | |
Secondary | Quality of life score | Quality of life assessed by Short-form 12 questionnaire | Week 24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|